Y.J.B. van Megen

Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial

Anne S. Strik, Wim van de Vrie, Joanne P J Bloemsaat-Minekus et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 63 citations

Veterinary Medicine, Immunology, Pharmacotherapy +11

Treatment With Prolonged-Release Oxycodone/Naloxone Improves Pain Relief and Opioid-Induced Constipation Compared With Prolonged-Release Oxycodone in Patients With Chronic Severe Pain and Laxative-Refractory Constipation

Jan Poelaert, Gineke Koopmans-Klein, Alioune Dioh et al. · Clinical Therapeutics · 2015 · 33 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17

Cholinergic muscarinic receptors in rat cochlea

Y.J.B. van Megen, A. B. M. Klaassen, Jaap F. Rodrigues de Miranda et al. · Brain Research · 1988 · 17 citations

Life Sciences, Neurobiology, Neuroscience +14

Characterization of muscarinic receptors in rat kidney

W. Matthijs Blankesteijn, Helene L.M. Siero, Jaap F. Rodrigues de Miranda et al. · European Journal of Pharmacology Molecular Pharmacology · 1993 · 12 citations

Medicine, Pharmacology, Molecular Pharmacology +13

Patient preference with respect to QoL and reduction in opioid‐induced constipation ( <scp>OIC</scp> ) after treatment with prolonged‐release ( <scp>PR</scp> ) oxycodone/naloxone compared with previous analgesic therapy [ <scp>PREFER</scp> study]

Van Dongen, Pascal Vanelderen, Gineke Koopmans-Klein et al. · International Journal of Clinical Practice · 2014 · 12 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17